http://huffingtonpost.amanda.com-weight-loss-tips.info/stand-for-israel
Will Diet Pill Maker Orexigen Benefit From Vivus' Troubles?
MINYANVILLE ORIGINAL It's been a rough week for diet pill maker Vivus (NASDAQ:VVUS). After disclosing Tuesday that early sales of its new weight-loss drug Qsymia is selling slower than expected and that challenges remain, the shares dropped ...
Read more on
No comments:
Post a Comment